Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours
Authors:
- 28 September 1996
- journal article
- Published by Wiley in Annals of Human Genetics
- Vol. 60 (5) , 369-376
Abstract
SUMMARY: The Min mouse is a model for human familial adenomatous polyposis (FAP), an autosomal dominant disease characterised by multiple adenomatous gastrointestinal polyps. The severity of the Min phenotype is modified by a locus (Mom1) on mouse chromosome 4, at a position syntenic with human chromosome 1p35‐p36. The secretory phospholipase A2 (Pla2s) gene is a candidate for this modifier locus and there is evidence that a locus on human chromosome 1p35‐p36 acts to modify the severity of human duodenal FAP. We have analysed the human secretory phospholipase A2 locus (PLA2G2A) for variants that could directly influence the FAP phenotype. We found no PLA2G2A variants predicted to result in functional variation in the phospholipase A2 protein. Two PLA2G2A polymorphisms were, however, discovered, one a ‘silent’ base change in exon 3 and another in a non‐coding region. Three other variants (possible mutations) were found in non‐coding regions. In 70 FAP patients from 20 families, no associations were found between the severity of duodenal polyposis and any PLA2G2A variant. One allele at the exon 3 polymorphic site did, however, occur more often then expected in patients with relatively severe colonie FAP. Although of borderline statistical significance, this association, if genuine, is likely to result from linkage disequilibrium between the PLA2G2A alleles studied and undetected genetic variation at a closely linked locus. The frequency of the alleles at both polymorphic sites has also been determined in the germ line of patients with sporadic colorectal adenomas and carcinomas and in random controls, but no differences were found among these groups. Our results suggest that PLA2G2A variants do not influence inherited or sporadic colonie tumours. A linked locus may be a modifier of human FAP, but does not influence the risk of colorectal tumours in the general population.Keywords
This publication has 15 references indexed in Scilit:
- A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36.Journal of Medical Genetics, 1996
- The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasiaCell, 1995
- Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis.Gut, 1994
- Association of the APC Tumor Suppressor Protein with CateninsScience, 1993
- Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouseCell, 1993
- Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC GeneScience, 1992
- Identification of FAP Locus Genes from Chromosome 5q21Science, 1991
- Identification and characterization of the familial adenomatous polyposis coli geneCell, 1991
- A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the MouseScience, 1990
- Chromosome 5 allele loss in human colorectal carcinomasNature, 1987